Validating sharepoint in a gmp environment Live xxx chat in china


07-Sep-2017 15:23

Risk-Based Approaches for Validating Enterprise Share Point Deployment in FDA-Regulated Environments Speaker: Daniel O’Connor, Innovocommerce LLC Date: Jan.

18, 2011 Description: This Webinar by Daniel O’Connor, Co-Founder, Innovo Commerce LLC, will introduce innovative best practice risk-based approaches to validating enterprise Microsoft Share Point deployments in FDA regulated environments.

Benefit from the informal surrounding to intensify business contacts and extend your network.

top 8.20 Chairman’s Opening Remarks Dr Kai Juergens, Senior Project Manager External Manufacturing, Bayer Pharma AG, Germany 8.30 Process Validation Review During Regulatory Inspections • Process validation definition and regulatory expectations • General considerations on process validation throughout the lifecycle • How to approach CPV • Observations reported during various regulatory inspections • Maintaining audit readiness with respect to Process Validation M.

KG, Germany 14.40 CPV Challenges with Outsourcing • Risks and benefits of outsourcing with regard to CPV • The manufacturer’s policy as framework • Definition of critical process paramaters • How to deal with legacy products • Challenges with the handover to external manufacturing partners Dr Kai Juergens, Senior Project Manager External Manufacturing, Bayer Pharma AG, Germany 15.30 Networking and Coffee Break 16.00 CPV in Practice – a Quality by Design Point of View • Development of a risk based control strategy • Measuring of product and process performance • Continuous evaluation of control strategy and feedback loops/revalidation • CPV and Validation Maintenance • CPV reporting - Dashboards • CPV in CMO collaborations Gabriele Gold, Head of Quality by Design, Process Development & Technical Services, Shire, Austria 16.50 SPC as Part of Continuous Validation • How can SPC be used in practice?

• SPC as proof of continuous validation • Process development, re-evaluation und definition of parameters • Challenges regarding the process performance validation approach Dr Per Vase, Managing Partner, Applied Manufacturing Science, NNE Pharmaplan, Denmark 17.40 Closing Remarks 18.30 Evening Reception Following the official part of the conference, Chem-Academy invites you to a social evening reception at an atmospheric local restaurant.

The presentation begins with a high level introduction to Share Point enterprise planning and deployment considerations for life science organizations that will consider use of validated applications.

legacy products Dr Philip Hoersch, Director QA - Validation/Risk Management/Trending, Vetter Pharma-Fertigung Gmb H & Co.Many Share Point users, however, find that the system lacks sufficient document control, training, and other business process automation capabilities.



And don't ask me what that sign says because I probably don't know. But I most likely know how to speak a language other than English. How else are we supposed to talk about other people in public? My parents programmed every second of my life before it was cool for parents to do that. In fact, they'll probably continue trying to set me up with their friends' sons. They might not think you're husband material (yet), but they will like you more if you eat.11. … continue reading »


Read more

We don’t find anything romantic about name tags, microphones and whistles – so we don’t use them! Daters that don’t like to settle and tend to set the trend rather than follow it. You will be sent a confirmation from us and your name will be noted on our Guest List.~~Do you screen your speed daters?… continue reading »


Read more

Benvenuto su CHAT MODELS, il primo sito con splendide modelle e ragazze in videochat!… continue reading »


Read more

The law is well settled that inadequacy of price alone, unless it indicates fraud, unfairness or some misconduct or mistake for which the purchaser should be held responsible, ordinarily is not a sufficient ground to set aside a sale. 229, 236 (1856) (holding that inadequacy of sale price–under 50% of fair market value–coupled with trustees failure to bring property fairly into the market due to deficient advertising, required vitiation of foreclosure sale); Hurlock, 98 Md. The trial judge made an explicit finding that the amount received from the sale was not grossly inadequate. LEXIS 176 (1993) as follows:“The very few cases in which the courts of this State have held, or even suggested, that the inadequacy of the price realized at a foreclosure sale, in and of itself, required that a sale not be ratified the ratio of the sale price to the asserted fair market value was less than the 37% ratio here, see, Mc Cartney, 282 Md. … continue reading »


Read more